From: Increased expression of Six1 correlates with progression and prognosis of prostate cancer
 |  | Univariate analysisa |  | Multivariate analysisb | ||
---|---|---|---|---|---|---|
Variable | All case | Mean (months) | χ 2 | P value | HR (95 % CI) | P value |
Agec |  |  | 6.487 | 0.011 | 2.220 (1.146–4.300) | 0.018 |
 ≤65 | 68 | 111.567 |  |  |  |  |
 >65 | 76 | 96.475 |  |  |  |  |
Histological grade |  |  | 4.312 | 0.038 | 0.696 (0.335–1.446) | 0.331 |
 G1 + G2 | 77 | 106.956 |  |  |  |  |
 G3 | 67 | 99.493 |  |  |  |  |
Clinical stage |  |  | 9.381 | 0.002 | 1.369 (0.312–6.004) | 0.677 |
 I + II | 40 | 114.868 |  |  |  |  |
 III + IV | 104 | 99.086 |  |  |  |  |
Gleason score |  |  | 9.273 | 0.002 | 1.246 (0.391–3.969) | 0.710 |
 1–7 | 54 | 111.779 |  |  |  |  |
 8–10 | 90 | 98.610 |  |  |  |  |
pT status |  |  | 9.381 | 0.002 | 1.369 (0.312–6.004) | 0.677 |
 T1 + T2 | 40 | 114.868 |  |  |  |  |
 T3 + T4 | 104 | 99.086 |  |  |  |  |
pN status |  |  | 13.772 | 0.000 | 1.710 (0.803–3.642) | 0.164 |
 N0 | 107 | 107.933 |  |  |  |  |
 N1 + N2 | 37 | 90.843 |  |  |  |  |
pM status |  |  | 1.529 | 0.216 | 1.162 (0.554–2.437) | 0.692 |
 M0 | 107 | 104.893 |  |  |  |  |
 M1 | 37 | 100.275 |  |  |  |  |
Six1 expression |  |  | 16.051 | 0.000 | 3.434 (1.168–10.100) | 0.025 |
 Low | 64 | 113.943 |  |  |  |  |
 High | 80 | 94.992 |  |  |  |  |